TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway

TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, accounting for approximately 30% to 40% of non-Hodgkin’s lymphomas (NHL). The administration of rituximab significantly improved the outcomes of DLBCL; however, the unavoidable development of resistance limits the long-ter...

Full description

Bibliographic Details
Main Authors: Xingxing Yu, Xin Wang, Xu Wang, Yi Zhou, Yanchun Li, Aiwei Wang, Tongtong Wang, Yihan An, Weidong Sun, Jing Du, Xiangmin Tong, Ying Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pharmacology
Subjects:
TEOA
diffuse large B-cell lymphoma
DNA damage
reactive oxygen species
p38 MAPK
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.554736/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.554736/full

Similar Items